Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss
Merck & Co. (MRK) is implementing strategic initiatives to counteract the impending loss of exclusivity for its key drug, KEYTRUDA. The company plans to innovate its portfolio with new products across oncology, cardiovascular, and other therapeutic areas, aiming for a shallow dip in revenues. Merck is also expanding its human health growth drivers and pursuing business development to double animal health revenue by the mid-2030s.